Clinical Trial Update: Pharmacological Reduction of Functional, Ischemic Mitral REgurgitation [Phase 4]

View source ↗

Summary

Phase 4 trial update on pharmacological reduction of functional ischemic mitral regurgitation completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Dysfunction
• Mitral Valve Insufficiency

Snippet

Sponsor: Asan Medical Center | Conditions: Mitral Valve Insufficiency, Left Ventricular Dysfunction | Phase 4 | Status: COMPLETED